Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 16, 2012EMBO Molecular MedicineOpen Access

Interaction between hepatic angiopoietin-like 6 and tumoural α6 integrin/E-cadherin drives liver metastasis by colorectal cancer cells, with high coexpression indicating poor prognosis.

View Full Paper
Ask AI
Bookmark
Share

Population

Colorectal cancer (CRC) cells and patients with advanced CRC

Design

Preclinical

Key result

Interaction between hepatic angiopoietin-like 6 and tumoural α6 integrin/E-cadherin drives liver metastasis by colorectal cancer cells, with high coexpression indicating poor prognosis.

Authors

SMSerena MarchiòMSMarco SosterSCSabrina Cardaci

Discussion

Loading...

Member takes

Overview

Hypothesis-generating for targeting angiopoietin-like 6 in CRC metastasis; clinical validation in humans is required before any practice change.

Structured PICO

P
Population
Colorectal cancer (CRC) cells and patients with advanced CRC
E
Exposure
CGIYRLRSC peptide
O
Outcome
Liver metastasis and homing of CRC cells

Identification of a specific ligand-receptor interaction driving CRC liver metastasis provides a potential therapeutic target and prognostic biomarker.

Cite This Study

Marchiò et al. (2012) studied Colorectal cancer. α6 integrin and E-cadherin coexpression was evaluated on Liver metastasis and prognosis. Interaction between hepatic angiopoietin-like 6 and tumoural α6 integrin/E-cadherin drives liver metastasis by colorectal cancer cells, with high coexpression indicating poor prognosis.

synapsesocial.com/papers/6a961f13347927d4d16c57a9https://doi.org/10.1002/emmm.201101164
View Full Paper
Ask AI
Bookmark
Share